Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Researchers at Wake Forest have isolated cells from amniotic fluid and, after multiplying the cells in the lab, are able to coax them into becoming a particular cell type.

Stem Cells from Amniotic Fluid
Cells collected during pregnancy could aid research and therapy

Source: “Isolation of Amniotic Stem Cell Lines with Potential for Therapy”
Paolo De Coppi et al.
Nature Biotechnology 25(1): 100-106

Results: Scientists have isolated stem cells from amniotic fluid and found that they appear to have properties similar to those of embryonic stem cells. The cells grew efficiently in the lab, doubling in number every 36 hours, and were able to develop into precursors of multiple tissue types, including brain tissue.

Why it matters: Unlike embryonic stem cells, cells routinely discarded during amniocentesis could be harvested without destroying human embryos, avoiding the ethical concerns that have slowed stem cell research. And unlike most adult stem cells, those derived from amniotic fluid appear to grow efficiently and can differentiate into multiple cell types, making them suitable for therapeutic and research uses.

Methods: The researchers, led by Anthony Atala at Wake Forest, collected samples of amniotic fluid and isolated cells that expressed a molecule unique to stem cells. They then grew the cells under different environmental and chemical conditions to trigger their differentiation into different cell types.

Next steps: The researchers plan to try to develop the cells for use in treating diseases. They’ll try to make nerves for Parkinson’s patients, for instance, or insulin-secreting cells for people with diabetes.

0 comments about this story. Start the discussion »

Credit: Wake Forest University School of Medicine

Tagged: Biomedicine, stem cells, brain, disease, memory, longevity, embryo

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me